Cytotoxic sigma-2 ligands trigger cancer cell death via cholesterol-induced-ER-stress
Article in Cell Death & Disease (May 2024)
The most recent citing publications are shown below. View all 69 publications that cite this research output on Dimensions.
The novel drug candidate S2/IAPinh improves survival in models of pancreatic and ovarian cancer
Article in Scientific Reports (March 2024)
Design and Synthesis of Orally Active Quinolyl Pyrazinamides as Sigma 2 Receptor Ligands for the Treatment of Pancreatic Cancer
Article in Journal of Medicinal Chemistry (January 2023)